ADAPALENE 0.3% / BENZOYL PEROXIDE 2.5% / NIACINAMIDE 4%
- Manufacturer
- Sincerus Florida, LLC
- Effective date
- 2020-06-03
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-05-31 20:32:51
Label at a glance#
ProductADAPALENE 0.3% / BENZOYL PEROXIDE 2.5% / NIACINAMIDE 4%
Active ingredientNIACINAMIDE, ADAPALENE, BENZOYL PEROXIDE
Label structure4 sections
Label contents#
Full prescribing information#
Sincerus Florida, LLC adverse reactions.
Active, inactive
NDC 72934-1005-2 ADAPALENE 0.3 / BENZOYL PEROXIDE 2.5 / NIACINAMIDE 4 gel 30gm
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ADAPALENE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a46239a7-5963-4008-8cbb-6b9000f497eb | Product name | 1 | 20250721 |
| b382b4e1-6b48-45f6-bffc-e61b00b0ce19 | Product name | 3 | 20250317 |
| d9d61457-6a5a-41fc-b418-e5479a2904b7 | Product name | 2 | 20230303 |
| 32012d5c-25ac-49c7-9d4c-1313177fff7c | Product name | 1 | 20230112 |
| 13e7e7e3-e885-4c79-af6d-dad1aedbb06e | Product name | 1 | 20220128 |
| 4a7d44fe-774d-404b-aad0-8a90fe78375a | Product name | 4 | 20211025 |
| 91d0a1ed-5d14-5017-c7aa-3602ee038695 | Product name | 3 | 20210111 |
| 3f45980c-c196-47e5-0e5e-48b7c57327c5 | Product name | 5 | 20200428 |
| d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b | Product name | 3 | 20200203 |
| ee5c6de5-d9cd-454f-b250-7b19e5cf2992 | Product name | 4 | 20190619 |
| ad75fcfd-a339-42a1-9c60-43ba2c654cfa | Product name | 1 | 20170810 |
| 5c3dfd42-8936-4261-a420-cfcbbf3030aa | Product name | 2 | 20161206 |
| 08f39758-2d46-8afe-73ca-39fe69052a2b | Product name | 1 | 20140508 |
| 8ae7bcde-1dd2-b073-852b-f464987f7427 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72934-1005-2 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-a7ff-a426-e053-dadaa90af4c2 | ADAPALENE 0.3% / BENZOYL PEROXIDE 2.5% / NIACINAMIDE 4% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72934-1005-2 | ADAPALENE 0.3% / BENZOYL PEROXIDE 2.5% / NIACINAMIDE 4% | 30 g in 1 BOTTLE, PUMP | GEL | 30 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72934-1005 | ADAPALENE 0.3% / BENZOYL PEROXIDE 2.5% / NIACINAMIDE 4% GEL [SINCERUS FLORIDA, LLC] | 2 | Legacy NDC, 1 package rows | 20200604_87391cb8-def0-a107-e053-2991aa0a561b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72934-1005-2 | GM - Gram | 72934-1005 | 0c6e6af6-ba5a-4d2c-b9bb-0aed75daff42 | 1 | 2020-02-13 |
Products#
Every source-derived product name is available through these pages.
- ADAPALENE 0.3% / BENZOYL PEROXIDE 2.5% / NIACINAMIDE 4%
- NIACINAMIDE
- ADAPALENE
- BENZOYL PEROXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72934-1005 | 72934-1005-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
| ADAPALENE | 1L4806J2QF | ACTIB |
| BENZOYL PEROXIDE | W9WZN9A0GM | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a731513c-c772-31e3-e053-2a95a90aba86 | 87391cb8-def0-a107-e053-2991aa0a561b | 2020-06-03 | Adverse reactions | a731513c-c772-31e3-e053-2a95a90aba86 87391cb8-def0-a107-e053-2991aa0a561b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


